Report cover image

Wound Gel Market Size, Share & Trends Analysis By Product (Dressings, Gels), By Antimicrobial Properties (Silver, Non Silver), By Application, By End Use, By Mode Of Purchase, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2033

Published Jun 12, 2025
Length 110 Pages
SKU # GV20191905

Description

Wound Gel Market Summary

The global wound gel market size was valued at USD 6.05 billion in 2024 and is projected to reach USD 9.68 billion by 2033, growing at a CAGR of 5.37% from 2025 to 2033. The demand for wound gel is rising owing to the increasing number of surgical cases and the growing burden of wounds.

According to the data published by the University of Hawaiʻi in February 2025, chronic wounds affect about 6.5 million individuals in the U.S. each year, contributing to an estimated USD 25 billion in healthcare costs. Such a high burden of wounds and growing healthcare expenditure globally is anticipated to drive the demand for wound gel in the coming years.

The rising number of surgical procedures worldwide is a significant driver for expanding the wound gels market. Surgical interventions often result in acute wounds that require effective post-operative care to minimize infection risk and promote faster healing. Advanced wound care products, particularly wound gels, are increasingly preferred due to their ability to maintain a moist wound environment, support autolytic debridement, and accelerate tissue regeneration. According to data published in the BMC Surgery journal in 2025, approximately 313 million surgical procedures are performed globally annually. This substantial volume underscores the growing demand for reliable and effective wound care solutions, reinforcing the critical role of wound gels in the post-surgical healing process.

In addition to traditional medical surgeries, the growing demand for cosmetic and plastic surgeries is expected to contribute significantly to the market's expansion.According to the 2023 Plastic Surgery Statistics Report by the American Society of Plastic Surgeons, there was a 5% increase in overall cosmetic procedures from 2022 to 2023, as illustrated in the graph below:

Wound gels play a vital role in post-operative care following cosmetic procedures. These gels are designed to manage incisions and minor surgical wounds by promoting moist wound healing, which helps reduce the risk of scarring, minimizes the chance of infection, and accelerates tissue regeneration. As a result, wound gels are becoming essential in both in-clinic post-surgical protocols and at-home aftercare routines within aesthetic medicine. With the high volume of cosmetic surgeries, the demand for wound gels is expected to rise accordingly.

Global Wound Gel Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the global wound gel market report based on product, antimicrobial properties, application, mode of purchase, distribution channel, end use, and region:
  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Dressings
  • Hydrogel dressing
  • Gelling fiber dressings
  • Others
  • Gels
  • Antimicrobial Properties Outlook (Revenue, USD Million, 2021 - 2033)
  • Silver (Ag+)
  • Non-Silver
  • Mode of Purchase Outlook (Revenue, USD Million, 2021 - 2033)
  • Prescription
  • Non-prescription
  • Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Offline
  • Online
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Chronic Wounds
  • Diabetic Foot Ulcers (DFUs)
  • Pressure Ulcers
  • Stage 1
  • Stage 2
  • Stage 3
  • Stage 4
  • Leg Ulcers
  • Acute Wounds
  • Surgical Incisions
  • Burns
  • 1st Degree
  • 2nd Degree
  • 3rd Degree
  • Lacerations, Abrasions
  • End Use Outlook (Revenue, USD Million, 2021-2033)
  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgery Centers
  • Homecare Settings
  • Long-Term Care Facilities
  • Others
  • Regional Outlook (Revenue, USD Million, 2021-2033)
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Thailand
  • Latin America
  • Brazil
  • Argentina
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
Please note The report will be delivered in 2-3 business days upon order notification.

Table of Contents

110 Pages
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Antimicrobial Properties
1.1.3. Application
1.1.4. Mode of Purchase
1.1.5. Distribution Channel
1.1.6. End-use
1.1.7. Regional scope
1.1.8. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Wound Gel Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing number of surgical procedures
3.2.1.2. Rising burden of wounds
3.2.1.3. Introduction of innovative and advanced wound gel
3.2.1.4. Growing shift towards antimicrobial products
3.2.2. Market restraint analysis
3.2.2.1. Recalls of wound gel
3.2.3. Market opportunity analysis
3.2.3.1. Growing number of clinical trials
3.2.3.2. Improvements in public and private healthcare infrastructure
3.2.3.3. Growth potential in emerging economies in the wound gel market
3.2.3.4. Rising number of road accidents and sports injuries
3.2.4. Market challenge analysis
3.2.4.1. Potential complications and risks associated with wound gel
3.3. Wound Gel Market Analysis Tools
3.3.1. Industry Analysis – Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political & Legal Landscape
3.3.2.2. Economic and Social Landscape
3.3.2.3. Technological landscape
Chapter 4. Wound Gel Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Wound Gel Market Product Movement Analysis
4.3. Global Wound Gel Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
4.4. Dressings
4.4.1. Dressings market estimates and forecasts for 2021 to 2033 (USD Million)
4.4.1.1. Hydrogel dressings
4.4.1.1.1. Hydrogel dressings market estimates and forecasts for 2021 to 2033 (USD Million)
4.4.1.2. Gelling fiber dressings
4.4.1.2.1. Gelling fiber dressings market estimates and forecasts for 2021 to 2033 (USD Million)
4.4.1.3. Others
4.4.1.3.1. Other market estimates and forecasts for 2021 to 2033 (USD Million)
4.5. Gels
4.5.1. Gels market estimates and forecasts for 2021 to 2033 (USD Million)
Chapter 5. Wound Gel Market: Antimicrobial Properties Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Wound Gel Market Antimicrobial Properties Movement Analysis
5.3. Global Wound Gel Market Size & Trend Analysis, by Antimicrobial Properties, 2021 to 2033 (USD Million)
5.4. Silver
5.4.1. Silvers market estimates and forecasts for 2021 to 2033 (USD Million)
5.5. Non Silver
5.5.1. Non-silver market estimates and forecasts for 2021 to 2033 (USD Million)
Chapter 6. Wound Gel Market: Application Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global Wound Gel Market Application Movement Analysis
6.3. Global Wound Gel Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
6.4. Chronic Wounds
6.4.1. Chronic wounds market estimates and forecasts for 2021 to 2033 (USD Million)
6.4.1.1. Diabetic foot ulcers
6.4.1.1.1. Diabetic foot ulcers market estimates and forecasts for 2021 to 2033 (USD Million)
6.4.1.2. Pressure ulcers
6.4.1.2.1. Pressure ulcers market estimates and forecasts for 2021 to 2033 (USD Million)
6.4.1.2.1.1. Stage 1
6.4.1.2.1.1.1. Stage 1 market estimates and forecasts for 2021 to 2033 (USD Million)
6.4.1.2.1.2. Stage 2
6.4.1.2.1.2.1. Stage 2 market estimates and forecasts for 2021 to 2033 (USD Million)
6.4.1.2.1.3. Stage 3
6.4.1.2.1.3.1. Stage 3 market estimates and forecasts for 2021 to 2033 (USD Million)
6.4.1.2.1.4. Stage 4
6.4.1.2.1.4.1. Stage 4 market estimates and forecasts for 2021 to 2033 (USD Million)
6.4.1.3. Leg ulcers
6.4.1.3.1. Leg ulcers market estimates and forecasts for 2021 to 2033 (USD Million)
6.5. Acute Wounds
6.5.1. Acute wounds market estimates and forecasts for 2021 to 2033 (USD Million)
6.5.1.1. Surgical incisions
6.5.1.1.1. Surgical incisions market estimates and forecasts for 2021 to 2033 (USD Million)
6.5.1.2. Burns
6.5.1.2.1. Burns market estimates and forecasts for 2021 to 2033 (USD Million)
6.5.1.2.1.1. 1st degree burns
6.5.1.2.1.1.1. 1st degree burns market estimates and forecasts for 2021 to 2033 (USD Million)
6.5.1.2.1.2. 2nd degree burns
6.5.1.2.1.2.1. 2nd degree burns market estimates and forecasts for 2021 to 2033 (USD Million)
6.5.1.2.1.3. 3rd degree burns
6.5.1.2.1.3.1. degree burns market estimates and forecasts for 2021 to 2033 (USD Million)
6.5.1.3. Lacerations & abrasions
6.5.1.3.1. Lacerations & abrasions market estimates and forecasts for 2021 to 2033 (USD Million)
Chapter 7. Wound Gel Market: Mode of Purchase Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Global Wound Gel Market Mode of Purchase Movement Analysis
7.3. Global Wound Gel Market Size & Trend Analysis, by Mode of Purchase, 2021 to 2033 (USD Million)
7.4. Prescription
7.4.1. Prescription market estimates and forecasts for 2021 to 2033 (USD Million)
7.5. Non-prescription
7.5.1. Non-prescription market estimates and forecasts for 2021 to 2033 (USD Million)
Chapter 8. Wound Gel Market: Distribution Channel Estimates & Trend Analysis
8.1. Segment Dashboard
8.2. Global Wound Gel Market Distribution Channel Movement Analysis
8.3. Global Wound Gel Market Size & Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
8.4. Offline
8.4.1. Offline market estimates and forecasts for 2021 to 2033 (USD Million)
8.5. Online
8.5.1. Online market estimates and forecasts for 2021 to 2033 (USD Million)
Chapter 9. Wound Gel Devices: End Use Estimates & Trend Analysis
9.1. Segment Dashboard
9.2. Global Wound Gel Market End Use Movement Analysis
9.3. Global Wound Gel Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
9.4. Hospitals
9.4.1. Hospitals market estimates and forecasts for 2021 to 2033 (USD Million)
9.5. Specialty Clinics
9.5.1. Specialty clinics market estimates and forecasts for 2021 to 2033 (USD Million)
9.6. Ambulatory Surgery Centers
9.6.1. Ambulatory surgery centers market estimates and forecasts for 2021 to 2033 (USD Million)
9.7. Homecare Settings
9.7.1. Homecare settings market estimates and forecasts for 2021 to 2033 (USD Million)
9.8. Long-Term Care Facilities
9.8.1. Long-term care facilities market estimates and forecasts for 2021 to 2033 (USD Million)
9.9. Others
9.9.1. Other market estimates and forecasts for 2021 to 2033 (USD Million)
Chapter 10. Wound Gel Market: Regional Estimates & Trend Analysis
10.1. Regional Dashboard
10.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
10.3. North America
10.3.1. Market estimates and forecast, 2021 - 2033 (Revenue, USD Million)
10.3.2. U.S.
10.3.2.1. Key country dynamics
10.3.2.2. Competitive scenario
10.3.2.3. Regulatory framework
10.3.2.4. Reimbursement scenario
10.3.2.5. U.S. market estimates and forecasts, 2021 - 2033
10.3.3. Canada
10.3.3.1. Key country dynamics
10.3.3.2. Competitive scenario
10.3.3.3. Regulatory framework
10.3.3.4. Reimbursement scenario
10.3.3.5. Canada market estimates and forecasts, 2021 - 2033
10.3.4. Mexico
10.3.4.1. Key country dynamics
10.3.4.2. Competitive scenario
10.3.4.3. Regulatory framework
10.3.4.4. Reimbursement scenario
10.3.4.5. Mexico market estimates and forecasts, 2021 - 2033
10.4. Europe
10.4.1. UK
10.4.1.1. Key country dynamics
10.4.1.2. Competitive scenario
10.4.1.3. Regulatory framework
10.4.1.4. Reimbursement scenario
10.4.1.5. UK market estimates and forecasts, 2021 - 2033
10.4.2. Germany
10.4.2.1. Key country dynamics
10.4.2.2. Competitive scenario
10.4.2.3. Regulatory framework
10.4.2.4. Reimbursement scenario
10.4.2.5. Germany market estimates and forecasts, 2021 - 2033
10.4.3. France
10.4.3.1. Key country dynamics
10.4.3.2. Competitive scenario
10.4.3.3. Regulatory framework
10.4.3.4. Reimbursement scenario
10.4.3.5. France market estimates and forecasts, 2021 - 2033
10.4.4. Italy
10.4.4.1. Key country dynamics
10.4.4.2. Competitive scenario
10.4.4.3. Regulatory framework
10.4.4.4. Reimbursement scenario
10.4.4.5. Italy market estimates and forecasts, 2021 - 2033
10.4.5. Spain
10.4.5.1. Key country dynamics
10.4.5.2. Competitive scenario
10.4.5.3. Regulatory framework
10.4.5.4. Reimbursement scenario
10.4.5.5. Spain market estimates and forecasts, 2021 - 2033
10.4.6. Denmark
10.4.6.1. Key country dynamics
10.4.6.2. Competitive scenario
10.4.6.3. Regulatory framework
10.4.6.4. Reimbursement scenario
10.4.6.5. Denmark market estimates and forecasts, 2021 - 2033
10.4.7. Sweden
10.4.7.1. Key country dynamics
10.4.7.2. Competitive scenario
10.4.7.3. Regulatory framework
10.4.7.4. Reimbursement scenario
10.4.7.5. Sweden market estimates and forecasts, 2021 - 2033
10.4.8. Norway
10.4.8.1. Key country dynamics
10.4.8.2. Competitive scenario
10.4.8.3. Regulatory framework
10.4.8.4. Reimbursement scenario
10.4.8.5. Norway market estimates and forecasts, 2021 - 2033
10.5. Asia Pacific
10.5.1. Japan
10.5.1.1. Key country dynamics
10.5.1.2. Competitive scenario
10.5.1.3. Regulatory framework
10.5.1.4. Reimbursement scenario
10.5.1.5. Japan market estimates and forecasts, 2021 - 2033
10.5.2. India
10.5.2.1. Key country dynamics
10.5.2.2. Competitive scenario
10.5.2.3. Regulatory framework
10.5.2.4. Reimbursement scenario
10.5.2.5. India market estimates and forecasts, 2021 - 2033
10.5.3. China
10.5.3.1. Key country dynamics
10.5.3.2. Competitive scenario
10.5.3.3. Regulatory framework
10.5.3.4. Reimbursement scenario
10.5.3.5. China market estimates and forecasts, 2021 - 2033
10.5.4. South Korea
10.5.4.1. Key country dynamics
10.5.4.2. Competitive scenario
10.5.4.3. Regulatory framework
10.5.4.4. Reimbursement scenario
10.5.4.5. South Korea market estimates and forecasts, 2021 - 2033
10.5.5. Australia
10.5.5.1. Key country dynamics
10.5.5.2. Competitive scenario
10.5.5.3. Regulatory framework
10.5.5.4. Reimbursement scenario
10.5.5.5. Australia market estimates and forecasts, 2021 - 2033
10.5.6. Thailand
10.5.6.1. Key country dynamics
10.5.6.2. Competitive scenario
10.5.6.3. Regulatory framework
10.5.6.4. Reimbursement scenario
10.5.6.5. Thailand market estimates and forecasts, 2021 - 2033
10.6. Latin America
10.6.1. Brazil
10.6.1.1. Key country dynamics
10.6.1.2. Competitive scenario
10.6.1.3. Regulatory framework
10.6.1.4. Reimbursement scenario
10.6.1.5. Brazil market estimates and forecasts, 2021 - 2033
10.6.2. Argentina
10.6.2.1. Key country dynamics
10.6.2.2. Competitive scenario
10.6.2.3. Regulatory framework
10.6.2.4. Reimbursement scenario
10.6.2.5. Argentina market estimates and forecasts, 2021 - 2033
10.7. MEA
10.7.1. South Africa
10.7.1.1. Key country dynamics
10.7.1.2. Competitive scenario
10.7.1.3. Regulatory framework
10.7.1.4. Reimbursement scenario
10.7.1.5. South Africa market estimates and forecasts, 2021 - 2033
10.7.2. Saudi Arabia
10.7.2.1. Key country dynamics
10.7.2.2. Competitive scenario
10.7.2.3. Regulatory framework
10.7.2.4. Reimbursement scenario
10.7.2.5. Saudi Arabia market estimates and forecasts, 2021 - 2033
10.7.3. UAE
10.7.3.1. Key country dynamics
10.7.3.2. Competitive scenario
10.7.3.3. Regulatory framework
10.7.3.4. Reimbursement scenario
10.7.3.5. UAE market estimates and forecasts, 2021 - 2033
10.7.4. Kuwait
10.7.4.1. Key country dynamics
10.7.4.2. Competitive scenario
10.7.4.3. Regulatory framework
10.7.4.4. Reimbursement scenario
10.7.4.5. Kuwait market estimates and forecasts, 2021 - 2033
Chapter 11. Competitive Landscape
11.1. Recent Developments & Impact Analysis, By Key Market Participants
11.2. Company/Competition Categorization
11.2.1. Innovators
11.3. Vendor Landscape
11.3.1. List of key distributors and channel partners
11.3.2. Key customers
11.3.3. Global Key company market share analysis, 2024
11.3.4. Coloplast Ltd
11.3.4.1. Company overview
11.3.4.2. Financial performance
11.3.4.3. Product benchmarking
11.3.4.4. Strategic initiatives
11.3.5. Medline Industries, LP
11.3.5.1. Company overview
11.3.5.2. Financial performance
11.3.5.3. Product benchmarking
11.3.5.4. Strategic initiatives
11.3.6. Mölnlycke Health Care AB
11.3.6.1. Company overview
11.3.6.2. Financial performance
11.3.6.3. Product benchmarking
11.3.6.4. Strategic initiatives
11.3.7. Solventum
11.3.7.1. Company overview
11.3.7.2. Financial performance
11.3.7.3. Product benchmarking
11.3.7.4. Strategic initiatives
11.3.8. Convatec Inc.
11.3.8.1. Company overview
11.3.8.2. Financial performance
11.3.8.3. Product benchmarking
11.3.8.4. Strategic initiatives
11.3.9. Smith+Nephew
11.3.9.1. Company overview
11.3.9.2. Financial performance
11.3.9.3. Product benchmarking
11.3.9.4. Strategic initiatives
11.3.10. B. Braun SE
11.3.10.1. Company overview
11.3.10.2. Financial performance
11.3.10.3. Product benchmarking
11.3.10.4. Strategic initiatives
11.3.11. DermaRite Industries, LLC.
11.3.11.1. Company overview
11.3.11.2. Financial performance
11.3.11.3. Product benchmarking
11.3.11.4. Strategic initiatives
11.3.12. Integra LifeSciences Corporation.
11.3.12.1. Company overview
11.3.12.2. Financial performance
11.3.12.3. Product benchmarking
11.3.12.4. Strategic initiatives
11.3.13. Axio Biosolutions Private Limited
11.3.13.1. Company overview
11.3.13.2. Financial performance
11.3.13.3. Product benchmarking
11.3.13.4. Strategic initiatives
11.3.14. Sanara MedTech Inc.
11.3.14.1. Company overview
11.3.14.2. Financial performance
11.3.14.3. Product benchmarking
11.3.14.4. Strategic initiatives
11.4. Heat Map Analysis/ Company Market Position Analysis
11.5. Estimated Company Market Share Analysis, 2024
11.6. List of Other Key Market Players
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.